142 related articles for article (PubMed ID: 32461586)
1. Interrogating the impact of KIR ligand mismatch in engraftment following HLA-disparate stem cell transplantation.
Li L; Kolk M; Fernandez-Vina M; de Lima M; Otegbeye F
Bone Marrow Transplant; 2020 Dec; 55(12):2294-2297. PubMed ID: 32461586
[TBL] [Abstract][Full Text] [Related]
2. Natural Killer Cell Alloreactivity Predicted By Killer Cell Immunoglobulin-Like Receptor Ligand Mismatch Does Not Impact Engraftment in Umbilical Cord Blood and Haploidentical Stem Cell Transplantation.
Otegbeye F; Vina MAF; Wang T; Bolon YT; Lazaryan A; Beitinjaneh A; Bhatt VR; Castillo P; Marsh SGE; Hildebrandt GC; Assal A; Brown VI; Hsu J; Spellman S; de Lima M; Lee SJ
Transplant Cell Ther; 2022 Aug; 28(8):483.e1-483.e7. PubMed ID: 35643351
[TBL] [Abstract][Full Text] [Related]
3. The beneficial role of inhibitory KIR genes of HLA class I NK epitopes in haploidentically mismatched stem cell allografts may be masked by residual donor-alloreactive T cells causing GVHD.
Bishara A; De Santis D; Witt CC; Brautbar C; Christiansen FT; Or R; Nagler A; Slavin S
Tissue Antigens; 2004 Mar; 63(3):204-11. PubMed ID: 14989709
[TBL] [Abstract][Full Text] [Related]
4. Impact of Natural Killer Cell-Associated Factors on Acute Leukemia Outcomes after Haploidentical Hematopoietic Stem Cell Transplantation with αβ T Cell Depletion in a Pediatric Cohort.
Glushkova S; Shelikhova L; Voronin K; Pershin D; Vedmedskaya V; Muzalevskii Y; Kazachenok A; Kurnikova E; Radygina S; Ilushina M; Khismatullina R; Maschan A; Maschan M
Transplant Cell Ther; 2024 Apr; 30(4):435.e1-435.e12. PubMed ID: 38278183
[TBL] [Abstract][Full Text] [Related]
5. The impact of donor and recipient KIR genes and KIR ligands on the occurrence of acute graft-versus-host disease and graft survival after HLA-identical sibling hematopoietic stem cell transplantation.
Hoseinian SA; Jafari D; Mahmoodi M; Alimoghaddam K; Ostadali M; Talebzadeh Bonakdar A; Foma AM; Yekaninejad MS; Amirzargar AA
Turk J Med Sci; 2018 Aug; 48(4):794-804. PubMed ID: 30119155
[TBL] [Abstract][Full Text] [Related]
6. Determination of donor-derived killer immunoglobulin-like receptor (KIR) by sequential genotyping in hematopoietic stem cell-transplanted patients.
Yoshizawa S; Kitahara T; Zhang Y; Akahane D; Gotoh M; Ohyashiki K; Ohyashiki M; Ohyashiki JH
Hematology; 2010 Dec; 15(6):397-405. PubMed ID: 21114902
[TBL] [Abstract][Full Text] [Related]
7. Donor and recipient HLA/KIR genotypes do not predict liver transplantation outcome.
Moroso V; van der Meer A; Tilanus HW; Kazemier G; van der Laan LJ; Metselaar HJ; Joosten I; Kwekkeboom J
Transpl Int; 2011 Sep; 24(9):932-42. PubMed ID: 21672051
[TBL] [Abstract][Full Text] [Related]
8. Donor-Recipient Matching for KIR Genotypes Reduces Chronic GVHD and Missing Inhibitory KIR Ligands Protect against Relapse after Myeloablative, HLA Matched Hematopoietic Cell Transplantation.
Faridi RM; Kemp TJ; Dharmani-Khan P; Lewis V; Tripathi G; Rajalingam R; Daly A; Berka N; Storek J; Masood Khan F
PLoS One; 2016; 11(6):e0158242. PubMed ID: 27341514
[TBL] [Abstract][Full Text] [Related]
9. Is there an impact of killer cell immunoglobulin-like receptors and KIR-ligand incompatibilities on outcomes after unrelated cord blood stem cell transplantation?
Willemze R; Ruggeri A; Purtill D; Rodrigues CA; Gluckman E; Rocha V;
Best Pract Res Clin Haematol; 2010 Jun; 23(2):283-90. PubMed ID: 20837340
[TBL] [Abstract][Full Text] [Related]
10. Donor and host coexpressing KIR ligands promote NK education after allogeneic hematopoietic stem cell transplantation.
Zhao XY; Yu XX; Xu ZL; Cao XH; Huo MR; Zhao XS; Chang YJ; Wang Y; Zhang XH; Xu LP; Liu KY; Huang XJ
Blood Adv; 2019 Dec; 3(24):4312-4325. PubMed ID: 31869417
[TBL] [Abstract][Full Text] [Related]
11. Selecting the Best Donor for Haploidentical Transplant: Impact of HLA, Killer Cell Immunoglobulin-Like Receptor Genotyping, and Other Clinical Variables.
Solomon SR; Aubrey MT; Zhang X; Piluso A; Freed BM; Brown S; Jackson KC; Morris LE; Holland HK; Solh MM; Bashey A
Biol Blood Marrow Transplant; 2018 Apr; 24(4):789-798. PubMed ID: 29355721
[TBL] [Abstract][Full Text] [Related]
12. Survival advantage with KIR ligand incompatibility in hematopoietic stem cell transplantation from unrelated donors.
Giebel S; Locatelli F; Lamparelli T; Velardi A; Davies S; Frumento G; Maccario R; Bonetti F; Wojnar J; Martinetti M; Frassoni F; Giorgiani G; Bacigalupo A; Holowiecki J
Blood; 2003 Aug; 102(3):814-9. PubMed ID: 12689936
[TBL] [Abstract][Full Text] [Related]
13. Comparison of NK alloreactivity prediction models based on KIR-MHC interactions in haematopoietic stem cell transplantation.
Dhuyser A; Remen T; Pérès M; Chamberlain-Evans V; Nemat-Gorgani N; Campidelli A; Clément S; Rubio MT; Trowsdale J; Aarnink A; Traherne J
Front Immunol; 2023; 14():1028162. PubMed ID: 36936953
[TBL] [Abstract][Full Text] [Related]
14. Role of natural killer cell alloreactivity in HLA-mismatched hematopoietic stem cell transplantation.
Ruggeri L; Capanni M; Casucci M; Volpi I; Tosti A; Perruccio K; Urbani E; Negrin RS; Martelli MF; Velardi A
Blood; 1999 Jul; 94(1):333-9. PubMed ID: 10381530
[TBL] [Abstract][Full Text] [Related]
15. Donor KIR3DL1/3DS1 gene and recipient Bw4 KIR ligand as prognostic markers for outcome in unrelated hematopoietic stem cell transplantation.
Gagne K; Busson M; Bignon JD; Balère-Appert ML; Loiseau P; Dormoy A; Dubois V; Perrier P; Jollet I; Bois M; Masson D; Moine A; Absi L; Blaise D; Charron D; Raffoux C;
Biol Blood Marrow Transplant; 2009 Nov; 15(11):1366-75. PubMed ID: 19822295
[TBL] [Abstract][Full Text] [Related]
16. How important is NK alloreactivity and KIR in allogeneic transplantation?
Shaffer BC; Hsu KC
Best Pract Res Clin Haematol; 2016 Dec; 29(4):351-358. PubMed ID: 27890259
[TBL] [Abstract][Full Text] [Related]
17. NK cell recovery, chimerism, function, and recognition in recipients of haploidentical hematopoietic cell transplantation following nonmyeloablative conditioning using a humanized anti-CD2 mAb, Medi-507.
Koenecke C; Shaffer J; Alexander SI; Preffer F; Dombkowski D; Saidman SL; Dey B; McAfee S; Spitzer TR; Sykes M
Exp Hematol; 2003 Oct; 31(10):911-23. PubMed ID: 14550807
[TBL] [Abstract][Full Text] [Related]
18. Donor-recipient killer immunoglobulin like receptor (KIR) genotype matching has a protective effect on chronic graft versus host disease and relapse incidence following HLA-identical sibling hematopoietic stem cell transplantation.
Sahin U; Dalva K; Gungor F; Ustun C; Beksac M
Ann Hematol; 2018 Jun; 97(6):1027-1039. PubMed ID: 29549412
[TBL] [Abstract][Full Text] [Related]
19. The impact of donor natural killer cell alloreactivity on allogeneic hematopoietic transplantation.
Ruggeri L; Capanni M; Mancusi A; Martelli MF; Velardi A
Transpl Immunol; 2005 Aug; 14(3-4):203-6. PubMed ID: 15982564
[TBL] [Abstract][Full Text] [Related]
20. Role of KIRs and KIR ligands in hematopoietic transplantation.
Velardi A
Curr Opin Immunol; 2008 Oct; 20(5):581-7. PubMed ID: 18675345
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
